Health

Health Policy Update: Compounding Peptides

Updated 2026-10-29 13:05 UTC 1 source Neutral

The U.S. Department of Health and Human Services (HHS) released a policy allowing compounding pharmacies to manufacture certain peptide products temporarily.

Coverage timeline — 1 article

STAT News

STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more

HHS released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products

2026-10-29 12:52 UTC